Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The London Metal Exchange (LME) recently announced that its planned hot-rolled coil (HRC) Shanghai cash-settled futures contract is scheduled to be officially launched for trading in October 2026.

The London Metal Exchange (LME) recently announced that its planned hot-rolled coil (HRC) Shanghai cash-settled futures contract is scheduled to be officially launched for trading in October 2026.

老虎证券老虎证券2026/06/17 11:35
Show original
The launch of this new futures product is aimed at providing participants in the global steel industry chain with a transparent and efficient risk management and pricing tool based on Shanghai market prices in China. The contract will be settled in cash, offering market participants a new financial derivative option to hedge against price volatility risk. This move marks an important step for LME in expanding its ferrous metal derivatives series and deepening its ties with the Asian market. The market widely expects that the listing of this contract will help enhance the influence and pricing transparency of Chinese steel prices in the international market.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11